European Union · Question · QUESTION_WRITTEN
E-10-2025-004571
Accessibility to teplizumab for type 1 diabetes – Territorial inequalities in access to diabetes care and technologies
Introduced
17 November 2025
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
23 February 2026
Records
Official question E-10-2025-004571 from European Union at European Parliament. Dated 17 November 2025. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
The availability of Teplizumab for type 1 diabetes patients – regional inequalities in access to treatment and technologies
QUESTION_WRITTEN · EN · 1 December 2025
The availability of Teplizumab for type 1 diabetes patients – regional inequalities in access to treatment and technologies
QUESTION_WRITTEN · EN · 1 December 2025
Answer
QUESTION_WRITTEN_ANSWER · 23 February 2026
Accessibilità al teplizumab per il diabete di tipo 1 – Disuguaglianze territoriali nell'accesso alle cure e alle tecnologie per il diabete
QUESTION_WRITTEN · IT · 1 December 2025
Accessibilità al teplizumab per il diabete di tipo 1 – Disuguaglianze territoriali nell'accesso alle cure e alle tecnologie per il diabete
QUESTION_WRITTEN · IT · 1 December 2025
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.